Last reviewed · How we verify
NBM-BMX softgel capsules
At a glance
| Generic name | NBM-BMX softgel capsules |
|---|---|
| Sponsor | NatureWise Biotech & Medicals Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer (PHASE1)
- A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NBM-BMX softgel capsules CI brief — competitive landscape report
- NBM-BMX softgel capsules updates RSS · CI watch RSS
- NatureWise Biotech & Medicals Corporation portfolio CI